Cost-Effectiveness of Smoking Cessation Interventions Integrated Into Lung Cancer Screening - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Economic Evaluation of Smoking Cessation Strategies within Lung Cancer Screening Programs

  • By

  • Pianpian Cao

  • Laney Smith

  • Emma Tian

  • Lou-Anne Chichester

  • Elizabeth Schofield

  • Randi M. Williams

  • Rafael Meza

  • Benjamin A. Toll

  • Jamie Ostroff

  • Elena B. Elkin

  • Steven S. Fu

  • Stephanie R. Land

  • Kathryn L. Taylor

  • Jinani Jayasekera

  • September 14, 2026

Share

Objective:

To analyze the cost-effectiveness of various smoking cessation interventions delivered in lung cancer screening settings.

Approach:
  • Study Design: The analysis utilized data from four completed SCALE trials, assessing 23 intervention arms differing in counseling and pharmacotherapy intensity.
  • Intervention Characteristics: Each intervention included counseling and pharmacotherapy, with intensity categorized based on expert opinion.
  • Outcome Measurement: The primary outcome was self-reported 7-day point prevalence abstinence assessed at 6 or 12 months post-randomization.
  • Modeling Approach: The study employed the CISNET microsimulation model to project long-term health and economic outcomes.
Key Findings:
  • The analysis included 23 intervention arms from four trials, focusing on varying intensities of counseling and pharmacotherapy.
  • Interventions were categorized into eight composite treatment classes based on counseling and pharmacotherapy intensity.
  • The study followed the CHEERS 2022 reporting guideline for economic evaluations.
Limitations:
  • Not all SCALE trials assessed long-term health and economic consequences.
  • Variability in race categorization and self-reporting may affect generalizability.

Original Source(s)

Related Content